Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC207 (Bedaquiline) for MDR-TB
NCT00910871Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of bedaquiline in Tuberculosis (TB), sponsored by Johnson & Johnson. Started Sep 2009; status: completed.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00910871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910871.